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Abstract: Ring-closing metathesis was used to construct the strained 11-membered ring of obtusallenes II 
(and IV).  Bromonium-ion induced transannular oxonium ion formation-fragmentation gave the 
macrocyclic carbon skeleton of obtusallene VII with a bromine atom at C-13 in line with a previously 
published hypothesis.  An additional brominated [5.5.1]bicyclotridecane adduct that must arise from a 
bromonium-ion induced transannular oxonium ion formation-fragmentation could also be isolated, 
suggesting that this adduct represents the core of an as yet undiscovered natural product.  An authentic 
sample of obtusallene V was studied by NMR spectroscopy and the position of the halogens at C-7 and C-
13 were reassigned on the basis of a 13C NMR chlorine-induced isotopic shift.  This revised structure was 
subsequently confirmed by X-ray crystallography.  These findings allow us to confidently conclude that the 
structures of obtusallenes VII and VI should also be reassigned. 
 
Introduction 
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 Recently one of us proposed an internally self-consistent hypothesis concerning 
the biosynthesis of the obtusallene family – complex halogenated C15-acetogenic marine 
natural products isolated from Laurencia species.  Multiple electrophilic bromination 
events are invoked.1,2,3  The hypothesis correctly predicts the macrocyclic carbon 
frameworks, and all relative and absolute stereochemistries of obtusallene I,4,5 
obtusallenes II and III,6 and obtusallene IV7,8 whose structures have all been 
unambiguously solved by X-ray crystallography. It also correctly predicts the 
macrocyclic carbon frameworks, and the absolute and relative stereochemistries of all the 
stereocentres for obtusallenes V-VII.9,10 Interestingly, while the reported structures of 
obtusallenes V-VII - as solved by NMR spectroscopy - show a bromine atom at C-7 and a 
chlorine atom at C-13, the hypothesis predicts that obtusallenes V-VII should bear a 
bromine atom at C-13 and a chlorine atom at C-7.1,11  This prediction arises from 
invoking an electrophilic bromination of the C12-13 trans-double bond in obtusallene II 
(1) to give bromonium ion A (Scheme 1), followed by transannular attack of the THF-
oxygen at C-12 to generate tricyclic oxonium ion B. This intermediate would 
subsequently undergo nucleophilic attack at C-6 by water with the signature inversion of 
stereochemistry.1  Thus, the hypothesis predicts that the actual structure of obtusallene 
VII is represented by compound 2.  Subsequently, invoking HBr elimination across C9-
10 and spiroketalization via electrophilic bromination or protonation of the resulting enol 
ether leads to the conclusion that obtusallene V and obtusallene VI may be represented by 
structures 3 and 4, respectively. Therefore there is a need to investigate the viability of 
this bromonium ion induced transannular oxonium ion formation-fragmentation 
3 
experimentally, in order to validate the proposed biosynthetic pathway and as a 
consequence, confirm or correct the reported structures of obtusallenes V-VII. 
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Scheme 1. Proposed bromonium ion-driven rearrangement from obtusallene II (R = R-
bromoallene) 
 
In this paper we show that i) strained macrocycles corresponding to obtusallene II can be 
prepared by ring-closing metathesis to give the desired E-olefin in an eleven-membered 
4 
ring; ii) bromonium-ion induced transannular oxonium ion formation-fragmentations 
occur as predicted to give macrocyclic carbon frameworks corresponding to obtusallene 
VII with a bromine atom at C-13. The results of these studies strongly support our 
biosynthetic hypothesis for the obtusallene family.  In addition, the isolation of a 
brominated [5.5.1]bicyclotridecane adduct that must also arise from a bromonium-ion 
induced transannular oxonium ion formation-fragmentation, suggests that this represents 
the core of an as yet undiscovered natural product. Furthermore, the observation of a 
chlorine induced isotopic shift at C-7 in the 13C NMR spectrum of an authentic sample of 
obtusallene V, and, an X-ray crystallographic determination of its structure allows for the 
definitive reassignment11 of obtusallene V as structure 3, and thence obtusallenes VI and 
VII as structures 4 and 2, respectively. 
 
Results and Discussion 
 
In order to synthesize a macrocyclic model substrate for our studies by ring-closing 
metathesis, alcohol 512 was activated by conversion to the bromide and immediate 
coupling13,14 with but-3-yn-1-ol to give diynene 6 (Scheme 2).  Cis-selective partial 
hydrogenation,14 and directed epoxidation15 of the resulting Z,Z-triene alcohol 7 gave 
epoxide 8.  Regioselective chloride ring-opening16 and protection of the primary alcohol 
gave chlorohydrin 9.  Biosynthetically-inspired electrophilic bromoetherification1,2 gave 
chlorobromotetrahydrofuran 10 as a single diastereoisomer in excellent yield with all the 
relative stereochemistry correctly set for the THF core of obtusallene II.  Deprotection to 
5 
alcohol 11 and allylation17 gave acyclic diene 12 ready for attempted ring-closing 
metathesis. 
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Scheme 2. Preparation of ring-closing metathesis substrate 12 
 
A second acyclic diene metathesis substrate with an acetate group rather than a chloride 
at the equivalent C-7 position of obtusallene II position was also prepared.  Allylation17 
of enantiopure diol 132 followed by acetylation gave diene 14 ready for ring-closing 
metathesis (Scheme 3).  The acetate group was purposefully introduced to act as a 
neighboring group participant in the oxonium ion fragmentation (vide infra). 
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Scheme 3. Preparation of ring-closing metathesis substrate 14 
 
The ring-closing metathesis of dienes 12 and 14 were then explored.  Although some 
spectacular macrocyclic ring-closing metatheses have been performed in recent years18 
the optimum catalyst and conditions tend to be highly substrate dependent.19  Inspection 
of the X-ray crystal structure of obtusallene II6 shows its double bond to be distorted 
away from planarity, indicative of strain in the macrocycle.  In addition, we required only 
the E-olefin, whereas macrocyclic ring-closing metathesis typically provides mixtures of 
E and Z olefins. Notwithstanding all these issues we were confident that the desired 
macrocycles could be constructed in this manner. After much optimization, both 
substrates 12 and 14 underwent ring-closing metathesis using a Hoveyda modified 
Grubbs catalyst20 to provide the macrocyclic E-olefins 15 and 16, respectively (Scheme 
4).21  These macrocyclic alkenes lack only the methyl and bromoallene substituents of 
obtusallene II (1) and should make excellent model systems to explore the proposed 
bromonium-ion induced transannular oxonium ion formation-fragmentation.22 
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Scheme 4.  Ring-closing metatheses to provide macrocycles 15 and 16. 
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Figure 1.  The molecular structure of 15-A, one of the three crystallographically 
independent molecules present in the crystals of 15. 
 
Figure 2.  The molecular structure of 16. 
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Macrocyclic alkenes 15 and 16 proved to be crystalline and their X-ray crystal structures 
(Figures 1, 2) were determined confirming the presence of the E-double bond in both 
cases.  A distortion of ca. 10 degrees of the double bond away from planarity in each case 
reveals significant strain and underscores further the utility and versatility of the ring-
closing metathesis reaction.  Macrocycles 15 and 16 have essentially identical 
conformations (Figure 3), and a comparison with the known X-ray crystal structure of 
obtusallene II revealed them to be essentially identical outside of a local change in 
conformation at C14-O-C4-C5 (Figure 4). Of particular note, the transannular separations 
between the THF oxygen and C-12 are ca. 2.78 Å and 2.780(2) Å in 1523 and 16 
respectively, distances considerably shorter than the sum of their van der Waal’s radii 
(ca. 3.22 Å), and serves to position the THF oxygen perfectly to trap any bromonium ion 
formed at C12-13.  Interestingly, bromonium ion formation on the exposed exo face of 
the alkene, as seen in the X-ray crystal structures for 1, 15 and 16, would lead to a 
product with the opposite configurations at C-12 and C-13 compared to obtusallene VII.  
The requisite stereochemistry for obtusallene VII implies bromonium ion formation on 
the buried endo face.  This dichotomy can be rationalized by consideration of Guella’s 
careful NMR studies on the obtusallenes.  According to these studies, in solution, 
obtusallenes bearing a trans-olefin in the macrocycle are characterized by conformational 
motion involving 180 degree flipping of the olefinic bond.7  Clearly, this would expose 
the other face of the alkene for bromonium ion formation. 
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Figure 3. Overlay of molecules 15-A (magenta) and 16 (green) showing the essentially 
identical conformations for the 5- and 11-membered ring system. 
 
 
 
Figure 4. Overlay of molecules 15-A (magenta) and 1 (green) showing the different 
conformations for the C14–O1–C4–C5 linkages. 
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Scheme 5.  Products isolated after bromonium-ion induced transannular oxonium ion 
formation-fragmentation of 15. 
 
 The reaction of macrocycle 15 with NBS was performed in chlorinated solvents 
saturated with water to encourage progression along the obtusallene VII manifold.  After 
20 d at rt approximately 50% of the NBS had been consumed and a complex mixture of 
products had been formed.  Extensive column chromatography led to the isolation of a 
mixture of two components in an approximate 3:2 ratio (8% yield).  It was evident by 1H 
NMR that there was no double bond, and mass spectrometry gave a molecular ion with a 
characteristic isotopic pattern indicating the presence of three bromine atoms and one 
chlorine atom. The structures of the two components were solved by X-ray 
crystallography (See Figure S9, SI) showing that they were the two diastereoisomers 17 
and 18 (Scheme 5).24 
These must have resulted from the predicted bromonium ion induced transannular 
oxonium ion formation-fragmentation (c.f., Scheme 1) where bromide, rather than water, 
is functioning as the nucleophile at C-6 with the signature inversion of stereochemistry. 
In this instance bromide anion presumably arises from the well-known tendency of NBS 
to produce molecular bromine.  It is also evident, by comparison of their 
stereochemistries at C-12 and C-13 that initial bromonium ion formation occurs on both 
11 
faces of the double bond of macrocycle 15.25  Most significantly, diastereomer 18 
represents the complete macrocyclic carbon framework, with the correct relative 
stereochemistries of the C-6, C-7, C-9, C-10, C12 and C-13 stereocentres for obtusallene 
VII, all of which derive from the initial stereocentres of chlorohydrin 9 and two 
subsequent electrophilic bromination events.  Despite the long reaction time, and low 
isolated yield this result shows that the proposed chemical pathway is perfectly feasible 
and is therefore completely consistent with our original hypothesis and further supports 
the reassignment of the structures of obtusallenes V-VII. 
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Scheme 6. Products isolated after bromonium-ion induced transannular oxonium ion 
formation-fragmentation of 16. 
 
Macrocycle 16 was also treated with NBS to give macrocycles 19 and 20 (Scheme 6). 
The desired bromonium-ion induced transannular oxonium ion formation-fragmentation 
(c.f., Scheme 1) has evidently occurred with neighboring group participation of the 
acetate followed by hydrolysis of the Woodward-type intermediate with adventitious 
water.  The structure of 19 was confirmed by X-ray crystallography (See Figure S10, SI), 
and the identity of 20 was confirmed by transforming them both into their bis-acetates 
12 
which proved to be identical i.e. 21.  Although the bromonium ion-induced oxonium ion 
formation-fragmentation has occurred, the stereochemistry at C-12 and C-13 in 19 and 20 
is the opposite to that observed in macrocycle 18 and in obtusallene VII.  This illustrates 
the delicate balance between conformers and reactivity that are clearly in operation here.  
Again, however, despite the poor yield and long reaction time a bromonium-ion induced 
transannular oxonium ion formation-fragmentation is clearly a viable chemical pathway. 
 In an effort to reduce the long reaction times, to increase the yield of these 
bromonium-ion induced transannular oxonium ion formation-fragmentation reactions, 
and to introduce an oxygen substituent at C-6 we made two key modifications to our 
reaction conditions on chloride-containing macrocycle 15.  We elected to catalyse the 
transfer of electrophilic bromine from NBS by the use of catalytic quantities of 
tetramethylguanidine.26  Secondly, we used organic soluble acetic acid as our oxygen-
based nucleophile.  Much to our delight, the desired bromonium-ion induced transannular 
oxonium ion formation-fragmentation (c.f., Scheme 1) occurred rapidly (<1 h) with 
incorporation of acetate at C-6 to give bromoacetate 22 (stereochemistry unassigned at C-
12 and C-13) in a much improved yield of 30% (Scheme 7).  This is highly significant 
since the requisite oxygen and halide functionalities have now been installed at C-6 and 
C-13, respectively, as hypothesized for obtusallene VII. Interestingly, bromoacetate 
[5.5.1]bicyclotridecane 23 was also isolated in 13% yield from this reaction and 
characterized by X-ray crystallography (See Figure S11, SI).  Evidently, 23 must also 
have been formed via bromonium-ion induced transannular oxonium ion formation (c.f., 
Scheme 1), but followed instead by nucleophilic attack of acetate at C-9 as witnessed by 
the inversion of (relative) stereochemistry at that position.  It is interesting to speculate on 
13 
the significance of adduct 23, whereby since the pathway leading to it is apparently 
competitive with that leading to the obtusallene VII framework 22, it may represent the 
core of an as yet undiscovered natural product from Laurencia species. 
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Scheme 7. Bromonium-ion induced transannular oxonium ion formation-fragmentation 
of 15 using NBS and AcOH catalyzed by TMG. 
 
 Finally, extensive NMR experiments on an authentic sample of obtusallene V led 
to an identical interpretation to that of Guella.9 Thus, 13C NMR analysis showed a 
resonance with a chemical shift of 57 ppm corresponding to C-7 and the carbon at C-13 
showed a resonance at 61 ppm, where one must bear a chlorine atom and one must bear a 
bromine atom.  Using the chlorine-induced isotopic shift method27,28 at 323K in C6D6 the 
resonance at 57 ppm resolved into two signals in a 3:1 ratio separated by 8 ppb (Figure 
5).  This definitively locates the chlorine atom at C-7 and the bromine atom at C-13 in 
obtusallene V directly in line with our hypothesis.  This previously liquid sample proved 
to be crystalline in our hands and the resulting X-ray crystal structure of obtusallene V 
(Figure 6) confirms these repositionings of the halogens, confirms all other relative and 
absolute stereochemistries, and confirms the structure of obtusallene V is that of 
compound 3. In light of this finding, and also our experimentally-observed bromonium-
14 
ion induced rearrangements of obtusallene II models to give obtusallene VII macrocyclic 
frameworks with a bromide at C-13 and a signature inversion of stereochemistry at C-6 in 
accordance with our hypothesis (c.f., Scheme 1), we now also reassign the structure of 
obtusallene VII as compound 2.  It follows also that obtusallene VI is reassigned as 
compound 4. 
QuickTime™ and a
TIFF (Uncompressed) decompressor
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Figure 5.  Chlorine isotope splitting of the 13C resonance of obtusallene V at 57.4 ppm: 
the data was zero-filled to give a digital resolution of 0.031 Hz per point. 
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Figure 6. The molecular structure of 3. 
 
Experimental section 
 
 (1R*,6E,9S*,10S*,12R*)-9-Bromo-12-chloro-4,13-dioxabicyclo[8.2.1]tridec-6-ene 
(15).  Tetrahydrofuran 12 (65 mg, 0.20 mmol) was dissolved in toluene (88 mL) and 
Hoveyda-Grubbs 1st Generation catalyst, Ru(Cl)2(PCy3)(=CH-2-(2-PrO)C6H4) [Cy = 
cyclohexyl] (15 mg, 0.02 mmol) was added in one portion. The yellow solution was 
heated to reflux for 18 h. The solvent was evaporated in vacuo and the resulting brown 
residue was purified by flash column chromatography (3:1 Pet. Ether:EtOAc) to give 
macrocycle 15 (20 mg, 34%) as a white solid: m.p. 96-98 °C (recrystallized from 
hexane); IR (neat) 2928, 2871, 1447 cm-1; 1H NMR (400 MHz, CDCl3) δ 5.75 (ddd, J = 
15.2, 10.7, 2.4 Hz, 1H), 5.60-5.52 (m, 1H), 4.76 (ddd, J = 9.2, 7.2, 5.6 Hz, 1H), 4.52 
(ddd, J =  12.5, 5.3, 4.0 Hz, 1H), 4.42 (app. dd, J = 4.0, 2.1 Hz, 1H), 4.26 (app. ddd, J =  
12.3, 4.3, 1.8 Hz, 1H), 4.06-4.01 (m, 2H), 3.44 (dd, J = 12.1, 10.6 Hz, 1H), 3.24 (dt, J =  
16 
12.0, 1.7 Hz, 1H), 2.93-2.86 (m, 1H), 2.57-2.36 (m, 3H), 1.73-1.55 (m, 2H); 13C NMR 
(100 MHz, CDCl3) δ 133.6, 125.0, 78.2, 76.6, 73.0, 67.5, 63.0, 50.1, 38.6, 37.5, 32.8; MS 
(CI+, NH3) m/z 299, 297 and 295 (M + H)+; HRMS (CI+, NH3) m/z calcd for 
C11H17O235Cl79Br (M + H)+ 295.0100, found 295.0107.   
(1R,6E,9S,10S,12R)-12-Acetoxy-9-bromo-4,13-dioxabicyclo[8.2.1]tridec-6-ene (16).  
Five identical simultaneous reactions were carried out according to the following 
protocol. Tetrahydrofuran 14 (0.055 g, 0.16 mmol) was dissolved in anhydrous toluene 
(10 mL). Aliquots of this solution (2 mL) were added to each of five reaction tubes, and 
toluene (8 mL) was added to each tube. Benzylidene Ru(Cl)2(PCy3)(=CH-2-(2-
PrO)C6H4) [Cy = cyclohexyl] (0.0115 g, 0.02 mmol) was dissolved in anhydrous toluene 
(10 mL) and 2 mL of this solution added to each of the five sealed tubes. Finally, 1,4-
benzoquinone (0.0079 g, 2.3 mmol) was dissolved in toluene (10 mL) and 2 mL of this 
solution added to each of the five tubes. The five reaction mixtures where then heated at 
reflux for 21 h. The reaction mixtures were allowed to warm to rt, combined and the 
solvent evaporated in vacuo. The residue was chromatographed (70:30 petroleum 
ether:Et2O to 30:70 petroleum ether:Et2O) to give macrocycle 16 (0.017 g, 33%) as a 
white solid; m.p. 145-147 °C (recrystallized from hexane); Rf 0.53 (petroleum ether : 
Et2O 30 : 70); [α]D -16.5 (c 0.9, CHCl3); IR (neat) 1736 cm-1;. 1H NMR (400 MHz; 
CDCl3) δ 5.73 (ddd, J = 15.2, 10.4, 2.4 Hz, 1H), 5.51-5.59 (m, 1H), 5.26-5.27 (br m, 
1H,), 4.60-4.65 (m, 1H), 4.46-4.51 (m, 1H), 4.22-4.26 (m, 1H), 3.99 (dt, J = 12.0, 3.0 Hz, 
1H), 3.93 (app. br d, J = 11.6 Hz, 1H), 3.41 (dd, J = 12.0, 10.8 Hz, 1H), 3.20 (app. t, J = 
12.2 Hz, 1H), 2.83-2.89 (m, 1H), 2.47-2.56 (m, 1H), 2.15-2.28 (m, 2H), 2.08 (s, 3H), 
1.62-1.70 (m, 1H), 1.35-1.42 (m, 1H); 13C NMR (100 MHz; CDCl3) δ 170.6, 133.4, 
17 
124.9, 78.4, 76.0, 75.7, 73.0, 67.5, 50.6, 37.2, 34.9, 31.1, 21.0; MS (CI+, NH3) m/z 338 
and 336 (M + NH4)+, 321 and 319 (M + H)+; HRMS (CI+, NH3) m/z calcd for 
C13H1979BrO4 (M + H)+ 319.0545, found 319.0554. Anal. Found: C, 49.03; H, 6.07. 
C13H19BrO4 requires C, 48.92, H, 6.00 %.   
(1S*,2R*,7S*,8R*,10S*,11S*)-8-chloro-4,13-dioxa-2,7,11-
tribromobicyclo[8.2.1]tridecane (17) and (1R*,2S*,7S*,8R*,10S*,11S*)-8-chloro-
4,13-dioxa-2,7,11-tribromobicyclo[8.2.1]tridecane (18).  Macrocyclic alkene 15 (34 
mg, 0.12 mmol) was dissolved in CDCl3 in an NMR tube and NBS (14 mg, 0.12 mmol) 
added. The mixture was shaken and left covered in foil for a period of 20 d. To the 
mixture was added CH2Cl2 (30 mL) and the solution washed with sodium bisulfite 
solution (20% w/w) (30 mL). The aqueous layer was extracted with CH2Cl2 (20 mL x 3), 
the combined organic layers washed with water (20 mL), brine (20 mL) dried over 
anhydrous MgSO4, filtered and concentrated in vacuo. The residue was purified by 
successive rounds of flash column chromatography (10:1 Pet. Ether:EtOAc) to give the 
title compounds 17 and 18 as an inseparable mixture in a ca. 3:2 ratio (4 mg, 8%) as a 
white solid. 1H NMR (400 MHz; CDCl3) δ 5.04 (br s, 1H 18,), 4.92-4.86 (m, 1H 17 + 1H 
18), 4.54-4.44 (m, 1H 17 + 1H 18), 4.26 (d, J = 11.0 Hz, 1H 17), 4.16-3.86 (m, 4H 17 + 
4H 18), 3.70-3.47 (m, 3H 17 + 3H 18), 3.10-2.98 (m, 1H 17), 2.92-2.74 (m, 1H 17 + 1H 
18), 2.60-2.37 (m, 2H 17 + 3H 18), 2.30-1.93 (m, 2H 17 + 2H 18); MS (CI+, NH3) m/z 
459, 457, 455, 453 (M + H)+; 476, 474, 472, 470 (M + NH4)+ HRMS (CI+, NH3) m/z 
calcd for C11H1779Br335ClO2 (M + H)+ 452.8467, found 452.8469.   
(1S,2R,7S,8R,10S,11S)-8-Acetoxy-2,11-dibromo-4,13-dioxa-7-
hydroxybicyclo[8.2.1]tridecane (19) and (1S,2R,7S,8R,10S,11S)-7-Acetoxy-2,11-
18 
dibromo-4,13-dioxa-8-hydroxybicyclo[8.2.1]tridecane (20).  Macrocyclic alkene 16 
(129 mg, 0.40 mmol) was dissolved in CH2Cl2 (13 mL) and NBS (72 mg, 0.40 mmol) 
added.  Periodically, the reaction mixture was worked up as for the conversion of 15 into 
18 and 19.  After 1H NMR analysis to monitor conversion, the crude mixture was re-
dissolved in CH2Cl2 (4 mL, 4 mL) and fresh NBS (72 mg, 144 mg) was added.  After the 
third cycle and a total of ca. 100 h reaction time, the mixture was worked up as usual and 
column chromatography (10:90 petroleum ether:Et2O and then 30:70 petroleum 
ether:CH2Cl2) gave first isohydroxydibromide 20 (3 mg, 2%) as a colourless oil: [α]D25 -
8.7 (c 0.16, CH2Cl2); IR (KBr) 3550-3100, 1729 cm-1; 1H NMR (500 MHz; CDCl3) δ 
4.77 (dd, J = 10.3, 4.5 Hz, 1H), 4.60 (ddd, J = 11.4, 6.8, 1.1 Hz, 1H), 4.48-4.06 (m, 2H), 
3.97 (dd, J = 11.9, 6.9 Hz, 1H), 3.83 (dd, J = 11.9, 1.8 Hz, 1H), 3.70 (ddd, J = 9.8, 3.6, 
2.8 Hz, 1H), 3.58 (app. t, J = 9.8, 1H) 2.78 (app. quint., J = 5.6 Hz, 1H), 2.45-2.34 (m, 
2H) 2.24 (ddd, J = 13.2, 9.8, 8.2, 1H) 2.09 (s, 3H), 1.84 (dt, J = 14.7, 4.4, 1H), 1.47 (ddd, 
J = 14.5, 11.2, 11.2 Hz, 1H) OH peak not observed; 13C NMR (125 MHz; CDCl3) 
δ 170.8, 81.7, 79.0, 77.7, 72.2, 71.5, 66.7, 50.1, 45.6, 39.9, 34.5, 29.0, 21.4; MS (CI+, 
NH3) m/z 436, 434, 432 (M + NH4)+, 419, 417, 415 (M + H)+; HRMS (CI+, NH3) m/z 
calcd for C13H21O579Br2 (M + H)+ 414.9756, found 414.9757, and second 
hydroxydibromide (19) (9 mg, 5%) as a white solid: m.p. 128-129˚C; [α]D25 -6.5 (c 0.47, 
CH2Cl2); IR (KBr) 3550-3200, 1727 cm-1; 1H NMR (500 MHz; CDCl3) δ 5.30 (br s, 1H), 
4.61 (m, 2H), 4.43 (br s, 1H) 4.34 (br s, 1H), 4.03-3.87 (m, 3H), 3.73-3.68 (m, 2H), 2.92 
(app. quint., J = 6.1 Hz, 1H), 2.77 (br d, J = 11.2 Hz, 1H), 2.36-2.21 (m, 2H), 2.19-2.09 
(m, 1H), 2.10 (s, 3H), 1.61-1.50 (m, 1H), OH peak not observed; 13C NMR (125 MHz; 
CDCl3) δ 170.5, 83.4, 77.7, 74.6, 74 (broad), 71.1, 66.8, 51.0, 49.0, 42.0, 35.1, 31.9, 21.3; 
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MS (CI+, NH3) m/z 436, 434, 432 (M + NH4)+, 419, 417, 415 (M + H)+; HRMS (CI+, 
NH3) m/z calcd for C13H21O579Br2 (M + H)+ 414.9756, found 414.9764.   
Chemical correlation of 19 and 20 by conversion into (1S,2R,7S,8R,10S,11S)-7,8-
Diacetoxy-2,11-dibromo-4,13-dioxabicyclo[8.2.1]tridecane (21).  To a stirred solution 
of alcohol 19 (4.7 mg, 0.011 mmol) in dichloromethane (0.4 mL) at 0˚C was added 
DMAP (1 mg), followed by a solution of acetic anhydride (4.5 μL, 0.047 mmol) and 
triethylamine (6.6 μL, 0.047 mmol) in dichloromethane (0.1 mL).  The mixture was 
allowed to warm to rt and stirred for 8 h.  The mixture was quenched with water and 
extracted with dichloromethane, and the combined organic phase was dried over 
magnesium sulfate.  The solids were removed by filtration and the solvent evaporated. 1H 
NMR analysis of the crude reaction mixture showed that the conversion to bis-acetate 21 
was quantitative.  Meanwhile, to a stirred solution of alcohol 20 (1.6 mg, 0.004 mmol) in 
dichloromethane (0.2 mL) at 0˚C was added DMAP (1 mg), followed by a solution of 
acetic anhydride (1.5 μL, 0.017 mmol) and triethylamine (2.5 μL, 0.017 mmol) in 
dichloromethane (0.03 mL).  The mixture was allowed to warm to rt and stirred for 8 h. 
The mixture was quenched with water, extracted with dichloromethane, and the 
combined organic phase was dried over magnesium sulfate. The solids were removed by 
filtration and the solvent evaporated. 1H NMR analysis of the crude reaction mixture 
showed approximately 60% conversion to the desired bis-acetate and comparison of the 
1H NMR spectra of the two samples revealed them to be identical. The samples were then 
combined, and purified by silica gel column chromatography (1:1 petroleum 
spirits/diethyl ether) to give bis-acetate 21 (3.8 mg, 55%) as a colourless oil: [α]D25 -47.0 
(c 0.24, CH2Cl2); IR (KBr) 1731 cm-1; 1H NMR (400 MHz; CDCl3) δ 5.31-5.25 (m, 2H), 
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4.46-4.41 (m, 1H), 4.15 (dd, J = 10.4, 1.2 Hz, 1H), 4.05-3.97 (m, 3H), 3.70 (dt, J = 12.4, 
2.0 Hz, 1H), 3.62-3.50 (m, 3H), 2.95 (app. quint. J = 7.2 Hz, 1H), 2.48-2.33 (m, 3H), 
2.08 (s, 3H), 2.06 (s, 3H) 1.37-1.31 (m, 1H); 13C NMR (100 MHz; CDCl3) δ 171.1, 
170.2, 82.7, 77.5, 75.8, 75.2 74.8 (broad), 50.6, 43.7, 35.6 (broad), 29.3, 21.2, 21.0; MS 
(CI+, NH3) m/z 478, 476, 474 (M + NH4)+; HRMS (CI+, NH3) m/z calcd for 
C15H26NO679Br2 (M + H)+ 474.0127, found 474.0123.  
(7S*,8R*,10S*,11S*)-7-Acetoxy-8-chloro-2,11-dibromo-4,13-
dioxabicyclo[8.2.1]tridecane (22) and (1R*,2S*,7R*,8R*,10R*,11S*)-10-Acetoxy-
2,11-dibromo-8-chloro-4,13-dioxabicyclo[5.5.1]tridecane (23). Macrocyclic alkene 15 
(8.0 mg, 27.1 μmol) was dissolved in CD2Cl2. Tetramethylguanidine in CH2Cl2 (0.032 M, 
10 μL, 0.32 μmol), AcOH in CH2Cl2 (2.62 M, 10 μL, 26.2 μmol) and NBS (4.8 mg, 27.1 
μmol) were added sequentially at ambient temperature. The mixture was stirred for 1 h 
and complete conversion of starting material was observed via TLC and 1H NMR 
analyses. To the mixture was added CH2Cl2 (30 mL) and the solution washed with 
sodium bisulfite solution (20% w/w) (30 mL). The aqueous layer was extracted with 
CH2Cl2 (20 mL x 3), the combined organic layers washed with water (20 mL), brine (20 
mL) dried over anhydrous MgSO4, filtered, concentrated and purified by flash column 
chromatography (5:1 Pet. Ether:EtOAc) to give first bromoacetate 22 (3.5 mg, 30 %) as a 
colorless oil: Rf = 0.61 (3:1 P.E:EtOAc); IR (KBr) 1731 cm-1; 1H NMR (400 MHz; 
CDCl3) δ 5.34 (br d, J = 7.3 Hz, 1H), 4.49 (br s, 2H), 4.22 (d, J = 11.0 Hz, 1H), 4.12 (br 
s, 1H), 3.95 (br s, 2H), 3.67 (br t, J = 12.3 Hz, 1H), 3.53-3.49 (m, 2H), 3.04-2.98 (m, 1H), 
2.64-2.55 (m, 2H), 2.37 (br d, J = 14.5 Hz, 1H), 2.16-2.13 (m, 1H), 2.07 (s, 3H), 1.45-
1.42 (m, 1H); 13C NMR (125 MHz; CDCl3) δ 171.1, 82.8, 77.2, 76.1, 76.0, 68.4, 64.5 
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(broad), 50.5, 49.7, 44.2, 40.6 (broad), 31.7, 21.2; MS (CI+, NH3) m/z 450, 452, 454, 456 
(M + NH4)+; HRMS (CI+, NH3) m/z calcd for C13H23NO479Br235Cl (M + NH4)+ 449.9682, 
found 449.9690; and second bromoacetate 23 (1.5 mg, 13 %) as white solid: m.p. 134-
136˚C (recrystallized from hexane); Rf = 0.42 (3:1 P.E:EtOAc); IR (KBr) 1733 cm-1; 1H 
NMR (500 MHz; CDCl3) δ 5.66 (d, J = 8.1 Hz, 1H), 4.62 (br s, 1H), 4.25 (dd, J = 12.6, 
3.4 Hz, 1H), 4.14-4.09 (m, 2H), 4.04 (ddd, J = 12.5, 5.9, 1.8 Hz, 1H), 3.92-3.88 (m, 2H); 
3.83 (dd, J = 12.6, 5.3 Hz, 1H), 3.77 (td, J =11.9, 4.6 Hz, 1H), 3.04 (ddd, J = 16.1, 8.1, 
2.1, 1H), 2.64 (ddd, J = 15.0, 4.4, 1.3 Hz, 1H) 2.42 (ddd, J = 14.9, 10.9, 3.2 Hz, 1H), 
2.34-2.27 (m, 1H), 2.15 (br dd, J= 16.1, 4.3 Hz, 1H), 2.08 (s, 3H), 1.53-1.45 (m, 1H); MS 
(CI+, NH3) m/z 450, 452, 454, 456 (M + NH4)+; HRMS (CI+, NH3) m/z calcd for 
C13H23NO479Br235Cl (M + NH4)+ 449.9682, found 449.9681.  
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